| Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies A Trickey, MT May, JJ Vehreschild, N Obel, MJ Gill, HM Crane, ... The lancet HIV 4 (8), e349-e356, 2017 | 1204 | 2017 |
| Poisson point process models solve the" pseudo-absence problem" for presence-only data in ecology DI Warton, LC Shepherd The Annals of Applied Statistics, 1383-1402, 2010 | 416 | 2010 |
| Incidences of severe hypoglycemia and diabetic ketoacidosis and prevalence of microvascular complications stratified by age and glycemic control in US adult patients with type … JH Pettus, FL Zhou, L Shepherd, R Preblick, PR Hunt, S Paranjape, ... Diabetes care 42 (12), 2220-2227, 2019 | 167 | 2019 |
| Cause-specific mortality in HIV-positive patients who survived ten years after starting antiretroviral therapy A Trickey, MT May, J Vehreschild, N Obel, MJ Gill, H Crane, C Boesecke, ... PloS one 11 (8), e0160460, 2016 | 142 | 2016 |
| Is Cohort Representativeness Passé? Poststratified associations of lifestyle risk factors with mortality in the UK Biobank E Stamatakis, KB Owen, L Shepherd, B Drayton, M Hamer, AE Bauman Epidemiology (Cambridge, Mass.) 32 (2), 179, 2021 | 134 | 2021 |
| Infection‐related and‐unrelated malignancies, HIV and the aging population L Shepherd, ÁH Borges, B Ledergerber, P Domingo, A Castagna, ... HIV medicine 17 (8), 590-600, 2016 | 92 | 2016 |
| Mortality according to CD4 count at start of combination antiretroviral therapy among HIV-infected patients followed for up to 15 years after start of treatment: collaborative … MT May, JJ Vehreschild, A Trickey, N Obel, P Reiss, F Bonnet, ... Clinical Infectious Diseases 62 (12), 1571-1577, 2016 | 91 | 2016 |
| Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus–coinfected Individuals From 2001 to 2014: A Multicohort Study LI Gjærde, L Shepherd, E Jablonowska, A Lazzarin, M Rougemont, ... Clinical infectious diseases 63 (6), 821-829, 2016 | 70 | 2016 |
| Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase Inhibitor–Based combination antiretroviral therapy: The D: A: D study M Bruyand, L Ryom, L Shepherd, G Fatkenheuer, A Grulich, P Reiss, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 68 (5), 568-577, 2015 | 64 | 2015 |
| Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected persons L Shepherd, JC Souberbielle, JP Bastard, S Fellahi, J Capeau, J Reekie, ... The Journal of infectious diseases 210 (2), 234-243, 2014 | 61 | 2014 |
| Increased non‐AIDS mortality among persons with AIDS‐defining events after antiretroviral therapy initiation AC Pettit, MJ Giganti, SM Ingle, MT May, BE Shepherd, MJ Gill, ... Journal of the International AIDS Society 21 (1), e25031, 2018 | 57 | 2018 |
| Smoking and use of primary care services: findings from a population-based cohort study linked with administrative claims data LR Jorm, LC Shepherd, KD Rogers, FM Blyth BMC health services research 12 (1), 1-10, 2012 | 55 | 2012 |
| Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across E urope M Mansfeld, A Skrahina, L Shepherd, A Schultze, AM Panteleev, RF Miller, ... HIV medicine 16 (9), 544-552, 2015 | 41 | 2015 |
| Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1–Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy L Gras, M May, LP Ryder, A Trickey, M Helleberg, N Obel, R Thiebaut, ... Journal of acquired immune deficiency syndromes (1999) 80 (3), 292, 2019 | 34 | 2019 |
| Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real‐world study of more than 30 000 patients in a US electronic health … JH Pettus, FL Zhou, L Shepherd, K Mercaldi, R Preblick, PR Hunt, ... Diabetes, Obesity and Metabolism 22 (4), 622-630, 2020 | 33 | 2020 |
| CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study L Wittkop, J Arsandaux, A Trevino, M Schim van der Loeff, J Anderson, ... Journal of Antimicrobial Chemotherapy 72 (10), 2869-2878, 2017 | 25 | 2017 |
| Glycemic control following GLP-1 RA or basal insulin initiation in real-world practice: a retrospective, observational, longitudinal cohort study XV Peng, RJ McCrimmon, L Shepherd, A Boss, R Lubwama, T Dex, ... Diabetes Therapy 11, 2629-2645, 2020 | 24 | 2020 |
| Cause‐specific mortality after diagnosis of cancer among HIV‐positive patients: A collaborative analysis of cohort studies A Trickey, MT May, MJ Gill, S Grabar, J Vehreschild, FWNM Wit, F Bonnet, ... International journal of cancer 146 (11), 3134-3146, 2020 | 24 | 2020 |
| Differences in virological and immunological risk factors for non-Hodgkin and Hodgkin lymphoma L Shepherd, L Ryom, M Law, CI Hatleberg, S De Wit, AA Monforte, ... JNCI: Journal of the National Cancer Institute 110 (6), 598-607, 2018 | 24 | 2018 |
| Cessation of cigarette smoking and the impact on cancer incidence in Human Immunodeficiency Virus–infected Persons: the data collection on adverse events of anti-HIV drugs study L Shepherd, L Ryom, M Law, K Petoumenos, CI Hatleberg, ... Clinical infectious diseases 68 (4), 650-657, 2019 | 23 | 2019 |
